De novo acute myeloid leukemia risk factors

被引:37
|
作者
Strom, Sara S. [1 ]
Oum, Robert
Gbito, Kplola Y. Elhor
Garcia-Manero, Guillermo [2 ]
Yamamura, Yuko
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Unit 1340, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
关键词
acute myeloid leukemia; epidemiology; risk factors; smoking; solvents; obesity; BODY-MASS INDEX; CIGARETTE-SMOKING; ADULT LEUKEMIA; MYELODYSPLASTIC SYNDROMES; OCCUPATIONAL EXPOSURE; LIFE-STYLE; BENZENE; MORTALITY; FEATURES; TOBACCO;
D O I
10.1002/cncr.27442
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Acute myeloid leukemia (AML) is comprised of several bone marrow-based cancers and is the most common type of leukemia in the United States. The etiology of AML is not well understood. A case-control study was conducted at The University of Texas M. D. Anderson Cancer Center to investigate associations between lifestyle characteristics and the risk of AML in Texas. METHODS: This study included 638 adult patients with de novo AML (cases) and a group of 636 matched controls. Interviewer-administered questionnaires were used to collect demographic and occupational data. The distribution of cases by World Health Organization (WHO) subtype was 71 patients (11%) with recurrent cytogenetic abnormalities (AML-RCA), 134 patients (21%) with multilineage dysplasia (AML-MD), and 389 patients (61%) with AML not otherwise categorized (AML-NOC). Multivariate logistic regression analyses were performed among all AML cases and among both sexes and each WHO subgroup. RESULTS: Among men, heavy smoking (=30 pack-years; odds ratio [OR], 1.86) and occupational solvent exposure at low levels (OR, 2.87) or moderate/high levels (OR, 4.13) statistically significantly increased the risk of AML. Among women, obesity (OR, 1.62) and solvent exposure to low levels (OR, 2.73) or moderate/high levels (OR, 3.90) increased the risk of AML. Across WHO subtypes, obesity was associated with a statistically significantly increased risk of AML-RCA (OR, 3.15), whereas solvent exposure increased the risk in all subtypes at low levels (AML-RCA: OR, 4.11; AML-MD: OR, 2.54) and moderate/high levels (AML-RCA: OR, 5.13; AML-MD: OR, 3.02). A joint effect between smoking and solvent exposure was observed, and the highest risk was observed among smokers who had solvent exposure (OR, 4.51). CONCLUSIONS: The current results suggested that several factors play a role in AML predisposition with possible joint effects. Risk profiles for AML differed by sex and WHO subtype. Cancer 2012.(c) 2012 American Cancer Society.
引用
收藏
页码:4589 / 4596
页数:8
相关论文
共 50 条
  • [41] The expression of mori protein in de novo acute myeloid leukemia with normal karyotype
    Cioch, M.
    Kocki, J.
    Jarosz, M.
    Dmoszynska, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 407 - 408
  • [42] Microsatellite instability is not an uncommon finding in adult de novo acute myeloid leukemia
    Nomdedéu, JF
    Perea, G
    Estivill, C
    Lasa, A
    Carnicer, MJ
    Brunet, S
    Aventín, A
    Sierra, J
    ANNALS OF HEMATOLOGY, 2005, 84 (06) : 368 - 375
  • [43] Overexpression of BAALC: clinical significance in Chinese de novo acute myeloid leukemia
    Jing-dong Zhou
    Lei Yang
    Ying-ying Zhang
    Jing Yang
    Xiang-mei Wen
    Hong Guo
    Dong-ming Yao
    Ji-chun Ma
    Qin Chen
    Jiang Lin
    Jun Qian
    Medical Oncology, 2015, 32
  • [44] Overexpression of BAALC: clinical significance in Chinese de novo acute myeloid leukemia
    Zhou, Jing-dong
    Yang, Lei
    Zhang, Ying-ying
    Yang, Jing
    Wen, Xiang-mei
    Guo, Hong
    Yao, Dong-ming
    Ma, Ji-chun
    Chen, Qin
    Lin, Jiang
    Qian, Jun
    MEDICAL ONCOLOGY, 2015, 32 (01)
  • [45] Microsatellite instability is not an uncommon finding in adult de novo acute myeloid leukemia
    Josep F. Nomdedéu
    Granada Perea
    Camino Estivill
    Adriana Lasa
    Maria J. Carnicer
    Salut Brunet
    Anna Aventín
    Jorge Sierra
    Annals of Hematology, 2005, 84 : 368 - 375
  • [46] Downregulated STAG2 expression in de novo acute myeloid leukemia
    Han, Q.
    He, X.
    Wu, L.
    Gao, F.
    Ye, J.
    Wu, L.
    Chen, L.
    Jiang, X.
    Sun, M.
    Chen, S.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1540 - 1540
  • [47] Reproducibility and prognostic significance of morphologic dysplasia in de novo acute myeloid leukemia
    Weinberg, Olga K.
    Pozdnyakova, Olga
    Campigotto, Federico
    DeAngelo, Daniel J.
    Stone, Richard M.
    Neuberg, Donna
    Hasserjian, Robert P.
    MODERN PATHOLOGY, 2015, 28 (07) : 965 - 976
  • [48] The Prognostic Value of D-Dimer in De Novo Acute Myeloid Leukemia
    Geng, Yudi
    Jian, Cui
    Yang, Shijia
    Wu, Sijing
    Zhou, Jianfeng
    Li, Dengju
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2016, 352 (02): : 129 - 133
  • [49] Next-generation sequencing panel in de novo acute myeloid leukemia
    Bolaman, A.
    Erdogdu, I.
    Turgutkaya, A.
    Selim, C.
    Kucukerdiler, A. Eroglu
    Meteoglu, I.
    Yavasoglu, I.
    LEUKEMIA RESEARCH, 2019, 85 : S69 - S70
  • [50] Myeloid/NK cell acute leukemia with unique blast morphology: de novo or secondary leukemia?
    Shinsaku Imashuku
    Naoko Kudo
    Park Sungkyu
    Masaya Shinbo
    Tatsuya Furukawa
    Shigenori Iwae
    International Journal of Hematology, 2013, 98 : 509 - 511